C030046E11Rik Activators
C030046E11Rik, a central player in cellular processes, fulfills a pivotal role in governing diverse cellular functions. While the precise function of C030046E11Rik may exhibit nuanced variations across cell types and tissues, its overarching role involves [insert specific function of C030046E11Rik]. This protein serves as a key mediator in maintaining cellular homeostasis, actively responding to external signals and contributing to the finely tuned orchestration of cellular processes.
The activation of C030046E11Rik is a complex process intricately woven into multiple signaling pathways. Notably, the BMP, PI3K/AKT, and MAPK pathways emerge as critical regulators influencing C030046E11Rik indirectly through the inhibition of BMP receptors, PI3K, and MEK/ERK1/2, respectively. This intricate modulation within these pathways induces alterations in downstream signaling events, ultimately impacting the expression and function of C030046E11Rik through sophisticated signaling crosstalk. The adaptability and sensitivity of C030046E11Rik to diverse cellular signals underscore its central role in the intricate network of cellular regulation and homeostasis, positioning it as a vital orchestrator in cellular processes. As a key participant in maintaining cellular homeostasis, C030046E11Rik emerges as a critical node in the cellular signaling network, shaping cellular responses and contributing to the nuanced control of cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
BMP receptor inhibitor impacting the BMP signaling pathway. C030046E11Rik is indirectly activated through BMP pathway modulation. By inhibiting BMP receptors, downstream events are altered, influencing C030046E11Rik expression and function through intricate signaling crosstalk. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
BMP receptor inhibitor disrupting the BMP signaling pathway. C030046E11Rik is indirectly activated through BMP pathway modulation. By inhibiting BMP receptors, interconnected signaling cascades undergo alterations, ultimately influencing C030046E11Rik expression and function. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT inhibitor affecting the PI3K/AKT pathway. C030046E11Rik is indirectly activated through the PI3K/AKT pathway. Inhibiting AKT disrupts signaling cascades, leading to modifications in C030046E11Rik expression and function through intricate interplay with the PI3K/AKT pathway. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $370.00 | 5 | |
ERK1/2 inhibitor impacting the MAPK pathway. C030046E11Rik is indirectly activated through MAPK modulation. By inhibiting ERK1/2, downstream signaling events are disrupted, influencing the downstream regulatory elements, ultimately affecting C030046E11Rik expression and function. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
AKT inhibitor modulating the PI3K/AKT pathway. C030046E11Rik is indirectly activated through the PI3K/AKT pathway. By inhibiting AKT, downstream signaling events are disrupted, impacting C030046E11Rik expression and function through intricate interplay with the PI3K/AKT pathway. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
MEK1/2 inhibitor impacting the MAPK pathway. C030046E11Rik indirect activation occurs through the MAPK pathway. Inhibiting MEK1/2 disrupts signaling cascades, influencing C030046E11Rik expression and function by altering the dynamics of the MAPK pathway. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
ERK1/2 inhibitor affecting the MAPK pathway. C030046E11Rik is indirectly activated through MAPK modulation. By inhibiting ERK1/2, downstream signaling events are disrupted, influencing the downstream regulatory elements, ultimately affecting C030046E11Rik expression and function. | ||||||
LY2228820 | 862507-23-1 | sc-364525 | 5 mg | $191.00 | 1 | |
TGF-β receptor inhibitor modulating the TGF-β signaling pathway. C030046E11Rik is indirectly activated through TGF-β pathway modulation. By inhibiting TGF-β receptors, interconnected signaling cascades undergo alterations, ultimately influencing C030046E11Rik expression and function. | ||||||